Nanotherapeutic Strategies for MASLD: From Pathological Mechanisms to Targeted Delivery Systems
Na Li, Dongqi Zhou, Fanghang Ye, Fei Yu, Liyuan Hao, Shenghao Li, Qing Peng, Jiali Deng, Xiaoyu Hu · 2026
Read Nanotherapeutic Strategies for MASLD: From Pathological Mechanisms to Targeted Delivery Systems by Na Li, Dongqi Zhou, Fanghang Ye, Fei Yu, Liyuan Hao, Shenghao Li, Qing Peng, Jiali Deng, Xiaoyu Hu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13546670.txt.
Description
Na Li and co-authors published a review in 2026 on tiny drug carriers for a serious liver disease linked to fat build-up. The disease harms liver cells, raises stress and swelling in the tissue, and can lead to scarring. Normal drugs often dissolve poorly, break down fast, or reach the wrong cells.
The review sorts new carrier designs by the harm they aim to treat and by the liver cell they aim to reach. It compares carriers made from minerals, plastics, fats, and living material. The authors note that most work is still early, and safety, large-scale making, and steady quality remain open problems. Readers get a map of which designs fit which stage of harm.
Catalog record
| CREATOR | Na Li, Dongqi Zhou, Fanghang Ye, Fei Yu, Liyuan Hao, Shenghao Li, Qing Peng, Jiali Deng, Xiaoyu Hu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 132 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |